Skip to main content
. 2022 Oct 24;12(17):7404–7419. doi: 10.7150/thno.75279

Figure 7.

Figure 7

(A) An illustration of in vivo 18F-FDG activated persistent luminescence imaging of ZGCs. (B) Representative luminescence images of 4T1 tumor-bearing mice after administration of only 200 μCi 18F-FDG or 200 μg ZGCs injection before 24 h and following with 200 µCi 18F-FDG. Reproduced with permission 61. Copyright 2020, Wiley-VCH.